Kids using Luminopia can now watch popular anime shows, further diversifying their content selection CAMBRIDGE, Mass., Oct. 28, 2025...
Exclusive partnership brings to the U.S. personalized AI preventive care platform, validated in clinical trials by the UK's NHS, to save employers billions of dollars and improve millions of lives LOUISVILLE, Ky....
In this free webinar, gain insights into identifying and evaluating emerging sites, including how sponsors can build trust in those...
In this free webinar, gain insight into the impact high-quality RWD can play when bringing a new therapy to market....
In this free webinar, gain insight into global IVD clinical performance study monitoring. Attendees will learn the common findings raised...
New AI-powered solution streamlines clinical trial operations, enhances patient-centric workflows, and accelerates clinical trial timelines. WILMINGTON, Del., Oct. 28, 2025...
HYDERABAD, India, Oct. 28, 2025 /PRNewswire/ -- According to Mordor Intelligence, the global clinical trials market is valued at USD 90.1...
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors...
ADELAIDE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning Australian led, global CRO built exclusively to service...
Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company...
Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing Study Has...
Ness-Ziona, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy...
IBSRELA patients reported treatment satisfaction in real-world survey Post-hoc analysis of T3MPO-1 and T3MPO-2 studies demonstrates effectiveness of IBSRELA in...
Karen Smith, MD, PhD, MBA, LLM, joins with over 25 years of global pharma and biotech experience, having contributed to...
SparingVision Doses First Patient with SPVN20 for Advanced Retinitis Pigmentosa in NYRVANA Trial SPVN20 aims to restore visual acuity...
BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),...
-- Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration...
The Special Meeting of Shareholders held on October 31, 2025 Shareholders vote on Equity Purchase Agreement with Sixth Borough Capital Fund...
Mr. Quigley most recently led McKinsey & Company’s Private Capital practice and previously led various Life Sciences practices at the...
To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programsTo bring deep expertise...